SEARCH HEALTH CONDITIONS BY ALPHABETS
Systemic Mast Cell Disease
Medications for Systemic Mastocytosis
Other names: Mastocytosis, Systemic; Systemic Mast Cell Disease
About Systemic Mastocytosis: Systemic mastocytosis is a disorder where there`s an increased number of mast cells within the skin, bone marrow and organs like liver, spleen, lymph nodes and gastro intestinal tract. The symptom severity changes from being mild to life threatening based on portions of the body which can be affected. Symptoms can include skin reactions, blood diseases liver, spleen or lymph nodes gastrointestinal effects like nausea diarrhea or vomiting.
Drugs Used to Address Systemic Mastocytosis
The following list of medications are somehow related to, or utilized in the treating this illness.
| Medication title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| cromolyn | Rx | B | N | 5 testimonials | 8.4 | ||
Generic title: cromolyn systemic Brand title: Gastrocrom Drug category: mast cell stabilizers For users: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Gastrocrom | Rx | B | N | Two testimonials | 8.6 | ||
Generic title: cromolyn systemic Drug category: mast cell stabilizers For users: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
| omeprazole | Rx/OTC | C | N | Insert inspection | 0.0 | ||
Generic title: omeprazole systemic Brand title: Prilosec Medicine category: proton pump inhibitors For users: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Gleevec | Rx | D | N | Insert inspection | 0.0 | ||
Generic title: imatinib systemic Medicine category: BCR-ABL tyrosine kinase inhibitors For users: dosage, interactions, and side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| Prilosec | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: omeprazole systemic Medicine category: proton pump inhibitors For users: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
| lansoprazole | Rx/OTC | B | N | Insert inspection | 0.0 | ||
Generic title: lansoprazole systemic Brand names: Prevacid, Prevacid OTC, Prevacid SoluTab Medicine category: proton pump inhibitors For users: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| imatinib | Rx | D | N | Insert inspection | 0.0 | ||
Generic title: imatinib systemic Brand title: Gleevec Medicine category: BCR-ABL tyrosine kinase inhibitors For users: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| midostaurin | Rx | N | 3 testimonials | 8.3 | |||
Generic title: midostaurin systemic Brand title: Rydapt Drug class: multikinase inhibitors For users: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph | |||||||
| Prevacid | Rx | B | N | Insert inspection | 0.0 | ||
Generic title: lansoprazole systemic Medicine category: proton pump inhibitors For users: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
| Rydapt | Rx | N | Two testimonials | 7.5 | |||
Generic title: midostaurin systemic Drug class: multikinase inhibitors For users: dosage, interactions, and side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| Prevacid OTC | OTC | B | N | Insert inspection | 0.0 | ||
Generic title: lansoprazole systemic Medicine category: proton pump inhibitors For users: dosage, interactions, side effects | |||||||
| Prevacid SoluTab | Rx | B | N | Insert inspection | 0.0 | ||
Generic title: lansoprazole systemic Medicine category: proton pump inhibitors For consumers: dosage, interactions, side effects | |||||||
Legend
| Rx | prescription-only |
|---|---|
| OTC | On the Counter |
| Rx/OTC | Prescription or Over The Counter |
| Away Tag | This medication might well not be accepted by the FDA for the treatment of this illness. |
| Pregnancy Category | |
|---|---|
| A | sufficient and well-controlled studies have failed to present a risk to the embryo in the first trimester of pregnancy (and there isn`t any evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to show a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women. |
| C | Animal reproduction studies have demonstrated an adverse impact on the fetus and there are no sufficient and well-controlled studies in humans, but possible benefits may warrant use in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may warrant use in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with use in pregnant women obviously outweigh potential gains. |
| N | FDA has not classified this medication. |
| Controlled Substances Act (CSA) Program | |
|---|---|
| N | isn`t at the mercy of the Controlled Substances Act. |
| Inch | features a high potential for misuse. Has no accepted medical use in treatment in the United States. There`s a lack of accepted safety for use under medical supervision. |
| Two | features a high potential for misuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may cause severe physical or psychological dependency. |
| 3 | includes a potential for abuse less than individuals in programs 1 and 2 two. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | features a very low potential for abuse in accordance with individuals in schedule 3. It`s a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to individuals in schedule 3. |
| 5 | features a very low potential for abuse in accordance with individuals in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence. |
| Alcohol | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Runciman
- S
- T
- U
- V
- W
- X
- Y
- Z
Further advice
Always consult with your physician to ensure the information displayed on these pages relates to your circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
